A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through GMP manufacturing and commercial supply.
Hartmut Tintrup, Executive Director, Commercial Development, FUJIFILM Biotechnologies
Advertisement
Articles by Hartmut Tintrup, Executive Director, Commercial Development, FUJIFILM Biotechnologies
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
4
Developing Next-Gen Cell Lines Using Targeted Integration
5